Sarcopenia Treatments Market Revenue 2024 to 2034
Sarcopenia Treatments Market Revenue 2024 to 2034
The Sarcopenia Treatments Market is projected to expand from USD 6.28 Bn in 2024 to USD 23.93 Bn by 2034, at a CAGR of 14.3%. Growth is driven by the rising elderly population, increasing prevalence of age-related muscle loss, advancements in regenerative therapies, and greater focus on healthy aging solutions.
Report ID: 10357
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 6.28 Bn
Forecast Year,
USD 23.93 Bn
CAGR, 2025 -
14.31%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Sarcopenia Treatments Market Size Analysis
Sarcopenia Treatments Market Size By Product & Service 2024 to 2034 (USD )
| Product & Service | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Products | 2.89 | 3.30 | 3.76 | 4.30 | 4.91 | 5.63 | 6.42 | 7.32 | 8.41 | 9.65 | 11.02 |
| Services | 2.26 | 2.59 | 2.97 | 3.39 | 3.88 | 4.41 | 5.03 | 5.78 | 6.58 | 7.50 | 8.58 |
| Software | 1.13 | 1.29 | 1.48 | 1.70 | 1.94 | 2.23 | 2.57 | 2.92 | 3.33 | 3.79 | 4.33 |
Sarcopenia Treatments Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical | 2.26 | 2.60 | 2.96 | 3.39 | 3.88 | 4.43 | 5.06 | 5.75 | 6.56 | 7.51 | 8.61 |
| Research | 1.76 | 2.01 | 2.30 | 2.64 | 3.03 | 3.49 | 3.98 | 4.56 | 5.22 | 5.95 | 6.80 |
| Operations | 1.51 | 1.72 | 1.97 | 2.23 | 2.53 | 2.89 | 3.30 | 3.79 | 4.33 | 4.96 | 5.65 |
| Others | 0.75 | 0.86 | 0.99 | 1.13 | 1.29 | 1.46 | 1.67 | 1.92 | 2.20 | 2.52 | 2.87 |
Sarcopenia Treatments Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals/Providers | 2.64 | 3.02 | 3.44 | 3.94 | 4.49 | 5.14 | 5.86 | 6.70 | 7.69 | 8.78 | 10.04 |
| Pharma & Biotech | 1.63 | 1.86 | 2.15 | 2.44 | 2.81 | 3.22 | 3.68 | 4.20 | 4.80 | 5.49 | 6.28 |
| Payers/Govt | 0.75 | 0.86 | 0.99 | 1.14 | 1.30 | 1.49 | 1.72 | 1.97 | 2.23 | 2.56 | 2.90 |
| Academic/Research | 1.01 | 1.15 | 1.30 | 1.48 | 1.70 | 1.93 | 2.19 | 2.50 | 2.85 | 3.26 | 3.73 |
| Others | 0.25 | 0.29 | 0.33 | 0.38 | 0.43 | 0.50 | 0.57 | 0.66 | 0.75 | 0.85 | 0.98 |
Sarcopenia Treatments Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.39 | 2.72 | 3.11 | 3.56 | 4.09 | 4.66 | 5.33 | 6.12 | 7.04 | 8.08 | 9.22 |
| Europe | 1.76 | 2.02 | 2.30 | 2.65 | 3.02 | 3.45 | 3.94 | 4.49 | 5.11 | 5.84 | 6.72 |
| Asia Pacific | 1.63 | 1.87 | 2.14 | 2.43 | 2.77 | 3.17 | 3.63 | 4.13 | 4.72 | 5.37 | 6.09 |
| Latin America | 0.25 | 0.29 | 0.33 | 0.38 | 0.43 | 0.49 | 0.56 | 0.63 | 0.72 | 0.82 | 0.94 |
| Middle East & Africa | 0.25 | 0.28 | 0.33 | 0.38 | 0.43 | 0.49 | 0.56 | 0.64 | 0.74 | 0.84 | 0.96 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
